ACTINOGEN MEDICAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.062 AUD | +34.78% |
|
+93.75% | +181.82% |
| 06-26 | Actinogen Medical Limited Announces the Peer-Reviewed Publication of its Phase 2a Biomarker | CI |
| 06-26 | Actinogen Medical's Xanamem Drug 'Potentially Slows' Progression of Alzheimer's Disease | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACTINOGEN MEDICAL LIMITED | Other Biotechnology & Medical Research | +34.78% | +93.75% | +181.82% | +47.62% | +520.00% | 111M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ACW Stock
- Charts Actinogen Medical Limited
- Comparison Chart
